Deutsche Bank upgraded Acadia Pharmaceuticals (ACAD) to Buy from Hold.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- Acadia Pharmaceuticals price target raised to $24 from $20 at Morgan Stanley
- Biotech Alert: Searches spiking for these stocks today
- Acadia Pharmaceuticals price target raised to $28 from $24 at BMO Capital
- Acadia Pharmaceuticals price target raised to $23 from $20 at Mizuho
- Acadia Pharmaceuticals price target raised to $31 from $28 at Baird